Back to User profile » Dr Lars Grönke

Papers published by Dr Lars Grönke:

Original Research

Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO® and OTEMTO® studies: a subgroup analysis by age

Ferguson GT, Karpel JP, Clerisme-Beaty E, Grönke L, Voß F, Buhl R

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:2701-2710

Published Date: 31 October 2016

Original Research

The efficacy and safety of combined tiotropium and olodaterol via the Respimat® inhaler in patients with COPD: results from the Japanese sub-population of the Tonado® studies

Ichinose M, Taniguchi H, Takizawa A, Grönke L, Loaiza L, Voß F, Zhao Y, Fukuchi Y

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:2017-2027

Published Date: 29 August 2016

Original Research

The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler® (ENERGITO® study)

Beeh KM, Derom E, Echave-Sustaeta J, Grönke L, Hamilton A, Zhai D, Bjermer L

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:193-205

Published Date: 3 February 2016